Pink Sheet Podcast: The Upcoming US FDA Commissioner Confirmation Hearing, Sublocade Loses Orphan Designation, Project Orbis Politics
Executive SummaryPink Sheet reporters look ahead to Stephen Hahn's Senate confirmation hearing, review the revocation of Indivior's buprenorphine orphan designation and consider Richard Pazdur's comments about external issues affecting Project Orbis.
You may also be interested in...
Efficacy data were striking to committee members, but they want to ensure postmarketing plans gather adequate data to address safety questions.
Keeping Track: Vascepa Adds CV Risk Reduction Claim, Vyondys 53 Get A Stunning Approval, And Submissions Pour Into FDA
The latest drug development news and highlights from our US FDA Performance Tracker.